@article{3077026,
    title = "Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb-IVB mycosis fungoides/Sézary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT)",
    author = "Stadler, R. and Romero, P.O. and Bagot, M. and Quaglino, P. and Guenova, E. and Jonak, C. and Papadavid, E. and Stranzenbach, R. and Sartori, D. and Musoro, J.Z. and Falato, C. and Marreaud, S. and Scarisbrick, J.J. and Knobler, R.",
    journal = "European journal of cancer (Oxford, England : 1990)",
    year = "2021",
    volume = "156",
    pages = "S22-S23",
    publisher = "NLM (Medline)",
    doi = "10.1016/S0959-8049(21)00668-7"
}